MDM2 regulates the stability of AR, AR-V7, and TM4SF3 proteins in prostate cancerPrabesh Khatiwada(Dana-Farber Cancer Institute), Lirim Shemshedini(University of Toledo)Endocrine OncologyJanuary 1, 202410.1530/eo-23-0017Cited by 6SaveCiteExport RISWatch citationsRelated PapersA Peptide against Soluble Guanylyl Cyclase α1: A New Approach to Treating Prostate Cancer|PLoS ONE|2013|18Zinc Finger 280B Regulates sGCα1 and p53 in Prostate Cancer Cells|PLoS ONE|2013|17Peptide B targets soluble guanylyl cyclase α1 and kills prostate cancer cells|PLoS ONE|2017|9Dual-Acting Peptides Target EZH2 and AR: A New Paradigm for Effective Treatment of Castration-Resistant Prostate Cancer|Endocrinology|2022|6